Title:Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications
VOLUME: 21 ISSUE: 7
Author(s):Jinling Qin, Weyland Cheng, Yong-Tao Duan, Hua Yang* and Yongfang Yao*
Affiliation:School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affilited to Zhengzhou University, Zhengzhou University, Henan 450018, Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affilited to Zhengzhou University, Zhengzhou University, Henan 450018, School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affilited to Zhengzhou University, Zhengzhou University, Henan 450018
Keywords:Heterocyclic compound, indazole, therapeutic application, structure-activity relationship, pharmacology, activity.
Abstract:Background: Heterocyclic compounds, also called heterocycles, are a major class of organic chemical
compound that plays a vital role in the metabolism of all living cells. The heterocyclic compound, indazole,
has attracted more attention in recent years and is widely present in numerous commercially available drugs.
Indazole-containing derivatives, representing one of the most important heterocycles in drug molecules, are
endowed with a broad range of biological properties.
Methods: A literature search was conducted in PubMed, Google Scholar and Web of Science regarding articles
related to indazole and its therapeutic application.
Results: The mechanism and structure-activity relationship of indazole and its derivatives were described. Based
on their versatile biological activities, the compounds were divided into six groups: anti-inflammatory, antibacterial,
anti-HIV, antiarrhythmic, antifungal and antitumour. At least 43 indazole-based therapeutic agents were
found to be used in clinical application or clinical trials.
Conclusion: This review is a guide for pharmacologists who are in search of valid preclinical/clinical drug
compounds where the progress of approved marketed drugs containing indazole scaffold is examined from 1966
to the present day. Future direction involves more diverse bioactive moieties with indazole scaffold and greater
insights into its mechanism.
